Search Bar & Filters
Found 31 Actively Recruiting clinical trials
Actively Recruiting
Diffuse large B-cell lymphoma DLBCL is the most common and aggressive subtype of non-Hodgkin lymphoma NHL, affecting many patients with rapid tumor growth and symptoms depending on tumor location. This observational study aims to understand the clinical characteristics, treatment patterns, and access to new therapies for patients with DLBCL in the Middle East and Africa region, including both newly diagnosed and relapsed or refractory cases. Participants are grouped into two cohorts those who are newly diagnosed and eligible for treatment, and those who have relapsed or are refractory after at least one prior therapy. The study does not involve experimental treatments but collects information on how patients are treated in real-world settings and explores access to innovative therapies. During the study, patient demographics, disease characteristics, risk profiles, and treatment patterns are documented over 22 months. Researchers will gather data through reviews of medical records and clinical information without administering treatments. The primary goal is to describe first-line and subsequent treatment approaches and to understand patient access to novel therapies for DLBCL.
Actively Recruiting
Researchers are studying nonspecific chronic low back pain NCLBP, focusing on how a new exercise method called Multi Angular Isometric Lumbar Exercise MAILE compares to traditional core stability and lumbar stabilization exercises. This trial aims to see if MAILE can better reduce pain, improve muscle strength and core stability, and enhance overall function. The study involves 98 patients and seeks to find a more effective and cost-efficient treatment option. Participants are randomly assigned to one of two groups for a three-week exercise program. One group performs MAILE, which targets deep lumbar muscles through angle-specific isometric exercises to improve spinal stability and reduce pain. The control group does traditional core stability and lumbar stabilization exercises to strengthen core muscles important for spinal support. Both approaches aim to improve pain levels, functional ability, and muscle strength. Throughout the study, participants are evaluated at the start, midpoint after 2 sessions, and end after 6 sessions for pain intensity using the Visual Analogue Scale, functional disability with the Oswestry Disability Index, muscle activation, and functional stability through balance and movement tests. Data on muscle strength and activation are also collected to assess treatment effects. The trial includes monitoring for physical risks like muscle soreness and fatigue, as well as psychological factors, over a total three-week intervention period.
Actively Recruiting
Researchers are investigating whether using portable air cleaners at home can lower exposure to fine particulate matter PM2.5 and improve health measures like blood pressure and blood sugar in adults with metabolic syndrome or type 2 diabetes living in Qatar. The study focuses on preventing cardiovascular problems linked to air pollution, which is a major risk factor worldwide. It aims to see if these air cleaners can have lasting effects over a week. Participants will use portable air cleaners with or without High Efficiency Particulate Air HEPA filters in their homes for one week each, in a randomized crossover design. This means each participant will experience both types of air cleaners in different periods. The devices are intended to reduce exposure to PM2.5, and the study compares the active HEPA filter cleaners to sham devices without the filter. During the study, participants blood pressure, blood sugar levels, and insulin resistance will be measured at various points up to 10 weeks. Researchers will collect these health measurements to assess changes linked to cleaner air exposure. The trial involves monitoring participants before, during, and after the air cleaner use, with visits to track health outcomes and ensure safety. The total participation lasts several weeks to capture both immediate and longer-term effects.
Actively Recruiting
Researchers are evaluating an online physical activity coaching program called Engage-Qatar PD designed for people with Parkinsons disease PD in Qatar. The study aims to develop and culturally adapt this program for online delivery, focusing on empowering individuals to overcome common barriers to exercise and improve their function and quality of life. This project builds on previous coaching interventions used in people with Huntingtons disease and PD, with a pilot randomized controlled trial planned to assess feasibility, acceptability, and potential benefits. Participants in the study will be randomly assigned to one of two groups. The intervention group will receive an 8-week personalized self-management program including one face-to-face coaching session and seven remote online sessions, supported by an online forum and a wearable smart watch for activity monitoring. The control group will receive standard physical activity recommendations for PD and a Fitbit watch for basic activity monitoring, but will not have access to the coaching or online forum. Both groups are encouraged, but not required, to wear their activity monitors during the intervention. During the study, participants will be assessed using various physical activity and health-related tests, including objective 7-day physical activity measurement, questionnaires on activity and symptoms, motor and cognitive function tests, and quality of life assessments. Researchers will monitor progress through wearable devices and regular coaching sessions. The study will last at least 8 weeks, with data collected on physical activity levels and other health outcomes to evaluate the programs impact and potential for wider implementation.
Actively Recruiting
Researchers are collecting real-world data in the Gulf Cooperation Council GCC countries on patients with hormone receptor-positive HR-positive, HER2-low or HER2-ultralow metastatic breast cancer mBC who have previously been treated with endocrine therapy. The study evaluates patient characteristics, treatment patterns, survival outcomes, and the safety of Trastuzumab Deruxtecan T-DXd to help optimize treatments and improve outcomes for mBC patients in the region. This observational study follows patients who have started treatment with T-DXd as part of their routine care. Eligible participants include female patients aged 18 years or older with confirmed HR-positive metastatic breast cancer classified as HER2-low or HER2-ultralow, who have received at least one prior line of endocrine therapy but no chemotherapy in the metastatic setting. Patients are observed for up to 18 months to assess treatment patterns and safety. Participants will have their health information collected and monitored, including progression-free survival, time to next treatment, safety profiles, and baseline characteristics. Data is gathered through routine clinical visits without intervention from the study team. The study duration extends through March 2029, allowing for long-term observation of treatment outcomes and patient experiences.
Actively Recruiting
Benign prostatic hyperplasia BPH is a common condition affecting men, especially with increasing age, and is one of the most performed surgical procedures in urology. This study establishes an ongoing international registry under uCARE to collect and analyze demographic data and clinical outcomes for men undergoing medical or surgical treatments for BPH. The registry aims to provide real-world data on treatment patterns and outcomes worldwide, helping to identify practice trends and preferences. Participants included are men aged 18 years and older diagnosed with BPH and lower urinary tract symptoms LUTS who have been prescribed either medications or surgical interventions for BPH. The registry records baseline demographic and clinical data, peri-operative details, and follow-up information using validated tools such as the International Prostate Symptom Score IPSS, Sexual Health Inventory for Men SHIM, and Male Sexual Health Questionnaire for Ejaculatory Dysfunction MSHQ-EjD, as well as clinical measures like quality of life, maximum flow rate, post-void residual, prostate-specific antigen, and testosterone levels. Complications including bleeding, urinary tract infections, incontinence, and sexual dysfunction are also tracked. Participants medical records are securely entered into the registry with data validation and periodic audits to ensure accuracy. Data collection continues for three years with no fixed endpoint for follow-up, allowing for ongoing research and publication of findings. Access to registry data is protected and restricted to site-specific users, ensuring patient privacy and data security. The registry aims to support future studies and improve understanding of BPH treatment outcomes globally.
Actively Recruiting
Hepatocellular carcinoma HCC is a common and serious cancer worldwide, often linked to cirrhosis caused by hepatitis B or C viruses and steatotic liver disease. This research focuses on understanding the causes, patient and tumor characteristics, treatments, and outcomes of HCC in adults across various countries in the Middle East and North Africa region, where the disease burden is significant. Differences in healthcare resources and access in these countries affect diagnosis and treatment outcomes. The study collects and reviews existing medical records of adult patients diagnosed with HCC between 2015 and 2023 in the MENA region. It examines details such as patient demographics, tumor features, risk factors, and treatment methods used. This observational study uses secondary data collection without administering any new treatments or interventions. Participants will have their clinical information, laboratory tests, imaging results, and treatment histories analyzed from medical records. The research team will assess outcomes like overall survival and progression-free survival over an eight-year period. Data completeness and follow-up for at least six months are required for inclusion. The study aims to improve understanding of HCC management and outcomes in this region through detailed data review.
Actively Recruiting
Healthy Volunteer
Researchers are comparing the effects of bio-ceramic sealers and resin-based sealers on the intensity and occurrence of postoperative pain following root canal treatment in adults with single-rooted teeth diagnosed with asymptomatic apical periodontitis. The study follows randomized controlled trial methods and aims to understand how these sealers influence pain and healing after endodontic procedures. Participants will receive root canal treatment using either a resin-based sealer AH plus sealer or a bio-ceramic sealer during the obturation process. Each sealer will be randomly assigned to patients treated at the Endodontic clinic of PHCC Qatar. The study observes the effects of these sealers on postoperative pain, analgesic intake, and any complications. Participants will be monitored for pain occurrence and intensity at 24 hours, 48 hours, and 7 days after treatment using a visual analog scale VAS and a postoperative pain questionnaire. Researchers will analyze pain intensity and analgesic use to compare outcomes between groups. The total participation involves these follow-up assessments to evaluate postoperative discomfort and treatment effects.
Actively Recruiting
Chronic Kidney Disease CKD is a major global health problem linked to cardiovascular issues, infections, cognitive decline, and increased death rates. In Qatar, about 13% of people have CKD, often facing challenges from taking many medications, which can reduce quality of life and cause negative health and financial effects. This research aims to create and test a multidisciplinary deprescribing program to manage medication use in CKD patients and improve their clinical and economic outcomes through a randomized controlled trial in Qatar. The study involves developing a deprescribing team and program to carefully review and adjust medications for patients with advanced CKD experiencing inappropriate polypharmacy. Patients will be randomized to either receive usual care or a structured deprescribing intervention provided by a multidisciplinary team. The intervention includes medication review by pharmacists and nephrologists, medication plan adjustments, follow-up calls by specialist nurses, and coordination with primary care providers. The study is conducted in three phases preparation, intervention, and post-intervention economic assessment. Participants will be monitored at baseline, 3 months, and 6 months for medication appropriateness, pill burden, quality of life, treatment burden, adherence, emergency visits, hospitalizations, adverse effects, and cost savings. Follow-up calls help identify withdrawal symptoms or concerns. The study evaluates the impact of deprescribing on health outcomes and healthcare costs over six months, aiming to support wider adoption of deprescribing programs in Qatars healthcare system.
Actively Recruiting
This trial studies children under 12 years old with hyperkalemia, a condition of elevated blood potassium levels. It aims to evaluate the pharmacodynamic effects, safety, and tolerability of patiromer, a drug being tested for managing high potassium in this young population. The study is a Phase 2, open-label trial sponsored by Vifor Pharma, Inc., focusing on this important treatment area for pediatric patients. Participants are grouped into three age cohorts 6 to less than 12 years, 2 to less than 6 years, and 0 to less than 2 years, with further subgroups in the youngest cohort. Patiromer is given once daily, with dosing possibly split for the youngest group depending on age and dose. The initial 4-week period evaluates pharmacodynamics and dose-ranging, with a possible extension up to 52 weeks for longer-term assessment. During the study, children will undergo regular potassium level testing and monitoring of vital signs such as heart rate and blood pressure. Laboratory tests will assess various blood chemistry and hematology parameters to monitor safety and treatment effects. Researchers will track adverse events and ECG changes. Participation involves scheduled visits and assessments up to one year, allowing detailed evaluation of patiromers impact and tolerability in children with hyperkalemia.
1-10 of 31
1